Haw Par Corporation Limited (SGX:H02)

Market Cap	3.10B -1.8%
Revenue (ttm)	219.55M -13.2%
Net Income	229.19M -8.5%
EPS	1.04 -8.5%
Shares Out	221.37M
PE Ratio	13.54
Forward PE	13.80
Dividend	0.40 (2.86%)
Ex-Dividend Date	Aug 24, 2026

Volume	321,500
Open	14.00
Previous Close	13.98
Day's Range	13.88 - 14.08
52-Week Range	13.91 - 18.27
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Haw Par Corporation

Established in Singapore in 1969, Haw Par Corporation Limited specializes in the manufacturing, marketing, and global trade of healthcare products, serving markets in Singapore, ASEAN countries, other Asian regions, and beyond. The company's business activities are structured into three main segments: Healthcare, Investments, and Others. Its Healthcare segment primarily produces and distributes topical pain relief solutions, prominently featuring the Tiger Balm and Kwan Loong brands. The Investments segment focuses on acquiring publicly traded ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1969
• Country: Singapore
• Stock Exchange: Singapore Exchange
• Ticker Symbol: H02

Financial Performance

In 2025, Haw Par Corporation's revenue was 229.97 million, a decrease of -6.07% compared to the previous year's 244.82 million. Earnings were 265.46 million, an increase of 16.29%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 4, 2026

Data Sources Report a data error